Stock ScreenerStock IdeasLow P/E RatioLow P/E Ratio StocksCompanies with P/E ratios below their industry and market average, with a minimum market cap of $250M+
Stock ScreenerStock IdeasLow P/E Ratio
Market Cap: >= $250M
P/E vs Industry: Pass
P/E vs Market: Pass
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOG.A | MOOG INC | $10.38B | $327.03 | $240.00 | -26.61% | Strong Buy | 1 | 7.79% | 18.97% | 19.54% | 8.87% | |||
| STRL | STERLING INFRASTRUCTURE INC | $12.61B | $410.63 | $407.00 | -0.88% | Strong Buy | 3 | 15.80% | 18.82% | 59.92% | 24.58% | |||
| CORT | CORCEPT THERAPEUTICS INC | $4.19B | $39.82 | $100.00 | 151.13% | Buy | 3 | 43.18% | 97.94% | 137.02% | 105.13% | |||
| DRS | LEONARDO DRS INC | $10.61B | $39.90 | $48.50 | 21.55% | Strong Buy | 2 | 6.40% | 15.66% | 16.74% | 10.44% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.28B | $283.29 | $332.29 | 17.30% | Strong Buy | 7 | 34.97% | 30.23% | 23.47% | 21.46% | |||
| JBL | JABIL INC | $27.51B | $260.54 | $264.75 | 1.62% | Strong Buy | 4 | 6.13% | 43.86% | 125.25% | 8.73% | |||
| DY | DYCOM INDUSTRIES INC | $11.95B | $412.68 | $392.44 | -4.90% | Strong Buy | 9 | 16.04% | 15.66% | 38.65% | 17.24% | |||
| WLDN | WILLDAN GROUP INC | $1.72B | $116.28 | $135.00 | 16.10% | Strong Buy | 2 | -37.12% | 56.00% | 23.65% | 13.18% | |||
| ORKA | ORUKA THERAPEUTICS INC | $1.56B | $32.27 | $53.56 | 65.96% | Strong Buy | 9 | N/A | N/A | -39.08% | -37.35% | |||
| ACA | ARCOSA INC | $6.04B | $123.08 | $115.00 | -6.56% | Strong Buy | 1 | 8.33% | 59.17% | 10.31% | 5.27% | |||
| RTX | RTX CORP | $274.91B | $204.81 | $207.50 | 1.31% | Buy | 8 | 6.47% | 18.01% | 17.40% | 6.63% | |||
| LHX | L3HARRIS TECHNOLOGIES INC | $65.77B | $352.12 | $378.33 | 7.44% | Strong Buy | 6 | 7.33% | 23.25% | 15.60% | 7.44% | |||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.02B | $64.38 | $89.75 | 39.41% | Strong Buy | 8 | -23.58% | N/A | -57.29% | -20.30% | |||
| MMSI | MERIT MEDICAL SYSTEMS INC | $4.92B | $82.98 | $103.50 | 24.73% | Strong Buy | 6 | 7.49% | 34.97% | 21.00% | 12.21% | |||
| GILT | GILAT SATELLITE NETWORKS LTD | $947.50M | $14.56 | $20.00 | 37.36% | Buy | 1 | 13.15% | 33.33% | N/A | N/A | |||
| BELFA | BEL FUSE INC | $2.62B | $206.83 | N/A | N/A | N/A | N/A | 12.70% | 46.99% | 24.75% | 11.11% | |||
| MYRG | MYR GROUP INC | $4.05B | $260.90 | $272.50 | 4.45% | Strong Buy | 4 | 9.92% | 22.49% | 40.58% | 15.23% | |||
| APH | AMPHENOL CORP | $181.59B | $147.73 | $163.20 | 10.47% | Strong Buy | 10 | 18.82% | 18.42% | 68.49% | 25.35% | |||
| TDG | TRANSDIGM GROUP INC | $74.28B | $1,315.33 | $1.56k | 18.53% | Strong Buy | 9 | 8.86% | 19.86% | -36.87% | 14.39% | |||
| AMAT | APPLIED MATERIALS INC | $292.83B | $369.30 | $377.33 | 2.18% | Strong Buy | 21 | 9.75% | 15.09% | 54.83% | 30.84% | |||
| STOK | STOKE THERAPEUTICS INC | $1.77B | $30.98 | $36.57 | 18.05% | Strong Buy | 7 | -26.98% | N/A | 10.63% | 9.09% | |||
| KLAC | KLA CORP | $194.03B | $1,480.30 | $1.65k | 11.37% | Strong Buy | 18 | 12.70% | 16.01% | 143.01% | 46.75% | |||
| SNDR | SCHNEIDER NATIONAL INC | $5.04B | $28.77 | $27.56 | -4.22% | Hold | 9 | 6.18% | 45.77% | 11.04% | 6.70% | |||
| MBUU | MALIBU BOATS INC | $592.49M | $31.85 | $33.50 | 5.18% | Hold | 4 | 3.66% | 69.10% | 20.66% | 14.29% | |||
| DGII | DIGI INTERNATIONAL INC | $1.87B | $49.64 | $48.80 | -1.69% | Strong Buy | 5 | 9.13% | 53.22% | 16.72% | 11.82% | |||
| COO | COOPER COMPANIES INC | $16.34B | $83.40 | $89.64 | 7.48% | Buy | 11 | 6.32% | 42.52% | 13.98% | 9.29% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.